Jubilant Pharmova Ltd
NSE:JUBLPHARMA

Watchlist Manager
Jubilant Pharmova Ltd Logo
Jubilant Pharmova Ltd
NSE:JUBLPHARMA
Watchlist
Price: 1 064.7 INR 0.29% Market Closed
Market Cap: 169.6B INR
Have any thoughts about
Jubilant Pharmova Ltd?
Write Note

Intrinsic Value

The intrinsic value of one JUBLPHARMA stock under the Base Case scenario is 904.27 INR. Compared to the current market price of 1 064.7 INR, Jubilant Pharmova Ltd is Overvalued by 15%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

JUBLPHARMA Intrinsic Value
904.27 INR
Overvaluation 15%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Jubilant Pharmova Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
JUBLPHARMA
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for JUBLPHARMA cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about JUBLPHARMA?
Bearish
Neutral
Bullish

Fundamental Analysis

1 064.7 INR
+0.29%
+0.29%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Jubilant Pharmova Ltd
IN
Pharmaceuticals
Market Cap
168.6B INR
IPO
Nov 9, 1994
Employees
36
India
Market Cap
168.6B INR
Industry
Pharmaceuticals
IPO
Nov 9, 1994
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Jubilant Pharmova Ltd

Provide an overview of the primary business activities
of Jubilant Pharmova Ltd.

What unique competitive advantages
does Jubilant Pharmova Ltd hold over its rivals?

What risks and challenges
does Jubilant Pharmova Ltd face in the near future?

Has there been any significant insider trading activity
in Jubilant Pharmova Ltd recently?

Summarize the latest earnings call
of Jubilant Pharmova Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Jubilant Pharmova Ltd.

Provide P/S
for Jubilant Pharmova Ltd.

Provide P/E
for Jubilant Pharmova Ltd.

Provide P/OCF
for Jubilant Pharmova Ltd.

Provide P/FCFE
for Jubilant Pharmova Ltd.

Provide P/B
for Jubilant Pharmova Ltd.

Provide EV/S
for Jubilant Pharmova Ltd.

Provide EV/GP
for Jubilant Pharmova Ltd.

Provide EV/EBITDA
for Jubilant Pharmova Ltd.

Provide EV/EBIT
for Jubilant Pharmova Ltd.

Provide EV/OCF
for Jubilant Pharmova Ltd.

Provide EV/FCFF
for Jubilant Pharmova Ltd.

Provide EV/IC
for Jubilant Pharmova Ltd.

Show me price targets
for Jubilant Pharmova Ltd made by professional analysts.

What are the Revenue projections
for Jubilant Pharmova Ltd?

How accurate were the past Revenue estimates
for Jubilant Pharmova Ltd?

What are the Net Income projections
for Jubilant Pharmova Ltd?

How accurate were the past Net Income estimates
for Jubilant Pharmova Ltd?

What are the EPS projections
for Jubilant Pharmova Ltd?

How accurate were the past EPS estimates
for Jubilant Pharmova Ltd?

What are the EBIT projections
for Jubilant Pharmova Ltd?

How accurate were the past EBIT estimates
for Jubilant Pharmova Ltd?

Compare the revenue forecasts
for Jubilant Pharmova Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Jubilant Pharmova Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Jubilant Pharmova Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Jubilant Pharmova Ltd compared to its peers.

Compare the P/E ratios
of Jubilant Pharmova Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Jubilant Pharmova Ltd with its peers.

Analyze the financial leverage
of Jubilant Pharmova Ltd compared to its main competitors.

Show all profitability ratios
for Jubilant Pharmova Ltd.

Provide ROE
for Jubilant Pharmova Ltd.

Provide ROA
for Jubilant Pharmova Ltd.

Provide ROIC
for Jubilant Pharmova Ltd.

Provide ROCE
for Jubilant Pharmova Ltd.

Provide Gross Margin
for Jubilant Pharmova Ltd.

Provide Operating Margin
for Jubilant Pharmova Ltd.

Provide Net Margin
for Jubilant Pharmova Ltd.

Provide FCF Margin
for Jubilant Pharmova Ltd.

Show all solvency ratios
for Jubilant Pharmova Ltd.

Provide D/E Ratio
for Jubilant Pharmova Ltd.

Provide D/A Ratio
for Jubilant Pharmova Ltd.

Provide Interest Coverage Ratio
for Jubilant Pharmova Ltd.

Provide Altman Z-Score Ratio
for Jubilant Pharmova Ltd.

Provide Quick Ratio
for Jubilant Pharmova Ltd.

Provide Current Ratio
for Jubilant Pharmova Ltd.

Provide Cash Ratio
for Jubilant Pharmova Ltd.

What is the historical Revenue growth
over the last 5 years for Jubilant Pharmova Ltd?

What is the historical Net Income growth
over the last 5 years for Jubilant Pharmova Ltd?

What is the current Free Cash Flow
of Jubilant Pharmova Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Jubilant Pharmova Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Jubilant Pharmova Ltd

Current Assets 35B
Cash & Short-Term Investments 12.9B
Receivables 8.3B
Other Current Assets 13.8B
Non-Current Assets 84.2B
Long-Term Investments 631m
PP&E 42.7B
Intangibles 35.5B
Other Non-Current Assets 5.4B
Current Liabilities 19.5B
Accounts Payable 8.3B
Other Current Liabilities 11.2B
Non-Current Liabilities 40.4B
Long-Term Debt 27.5B
Other Non-Current Liabilities 12.9B
Efficiency

Earnings Waterfall
Jubilant Pharmova Ltd

Revenue
69.2B INR
Cost of Revenue
-21.8B INR
Gross Profit
47.4B INR
Operating Expenses
-40.9B INR
Operating Income
6.5B INR
Other Expenses
-595m INR
Net Income
5.9B INR

Free Cash Flow Analysis
Jubilant Pharmova Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

JUBLPHARMA Profitability Score
Profitability Due Diligence

Jubilant Pharmova Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Revenue Growth Forecast
Negative Free Cash Flow
Positive 1-Year Revenue Growth
50/100
Profitability
Score

Jubilant Pharmova Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

JUBLPHARMA Solvency Score
Solvency Due Diligence

Jubilant Pharmova Ltd's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Low D/E
High Altman Z-Score
Long-Term Solvency
Short-Term Solvency
50/100
Solvency
Score

Jubilant Pharmova Ltd's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

JUBLPHARMA Price Targets Summary
Jubilant Pharmova Ltd

Wall Street analysts forecast JUBLPHARMA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for JUBLPHARMA is 1 357.62 INR with a low forecast of 1 224.12 INR and a high forecast of 1 522.5 INR.

Lowest
Price Target
1 224.12 INR
15% Upside
Average
Price Target
1 357.62 INR
28% Upside
Highest
Price Target
1 522.5 INR
43% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for JUBLPHARMA?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for JUBLPHARMA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

JUBLPHARMA Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

See Also

Discover More
What is the Intrinsic Value of one JUBLPHARMA stock?

The intrinsic value of one JUBLPHARMA stock under the Base Case scenario is 904.27 INR.

Is JUBLPHARMA stock undervalued or overvalued?

Compared to the current market price of 1 064.7 INR, Jubilant Pharmova Ltd is Overvalued by 15%.

Back to Top